Gonadorelin GND
GnRH decapeptide
Synthetic decapeptide identical to native GnRH, stimulating pituitary LH and FSH release and used as a diagnostic stimulus of pituitary function.
Evidence level. Published human clinical data exists, from trials or approved use. About the badges
- Class
- GnRH decapeptide
- Category
- Reproductive & Endocrine
- Type
- Single compound
- Abbreviation
- GND
- Development and regulatory status
- Veterinary use; diagnostic agent in some regions; no US human approval
What researchers study
Synthetic decapeptide identical to native hypothalamic gonadotropin-releasing hormone (GnRH). It binds pituitary GnRH receptors and stimulates release of LH and FSH, and is used as a diagnostic stimulus of pituitary function.
Research areas
- Pituitary LH and FSH release studies
- Stimulation-test comparisons in precocious puberty
- Livestock ovulation-timing studies
- Veterinary reproduction research
Reported findings
Summaries of published results. Each one is tagged with the type of study behind it. They describe research outcomes and are not claims about any product. Why study type matters.
- human retrospective study
In a retrospective study of 234 girls with precocious puberty, peak LH and FSH after gonadorelin stimulation were lower in overweight than normal-weight girls
- swine
In 285 sows, ovulation timing did not differ significantly between gonadorelin, recombinant hCG and buserelin under an estrus-triggered protocol
Studied alongside
Compounds that appear together in research because their mechanisms complement each other, or as comparators. The reasons given are research reasoning, not recommendations for use.
- Triptorelin AcetateGnRH agonist compared with gonadorelin in stimulation tests
- HCGLH-like hormone compared with gonadorelin as an ovulation trigger
- Kisspeptin-10upstream regulator of GnRH neurons
- AlarelinGnRH agonist compared with native GnRH in pituitary-response studies
